BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36523492)

  • 1. Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression.
    Yu M; Yang Y; Zhao H; Li M; Chen J; Wang B; Xiao T; Huang C; Zhao H; Zhou W; Zhang JV
    Front Pharmacol; 2022; 13():985618. PubMed ID: 36523492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMKLR1 Antagonist Alpha-NETA Protects against Diabetic Nephropathy in Mice.
    Peng Z; Wang X; Zhu Q; Wang H; Li B; Pang X; Han J
    Kidney Blood Press Res; 2023; 48(1):405-413. PubMed ID: 37231814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability
    Tümmler C; Snapkov I; Wickström M; Moens U; Ljungblad L; Maria Elfman LH; Winberg JO; Kogner P; Johnsen JI; Sveinbjørnsson B
    Oncotarget; 2017 Nov; 8(56):95135-95151. PubMed ID: 29221117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis progression.
    Zheng C; Zheng Y; Chen X; Zhong X; Zheng X; Yang S; Zheng Z
    BMC Endocr Disord; 2023 Jan; 23(1):9. PubMed ID: 36624417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-NETA, as a CMKLR1 Small Molecule Antagonist, Protects against Renal Ischemia Reperfusion Injury in Mice.
    Peng X; Wang W; Wang W; Qi J
    Protein Pept Lett; 2022; 29(11):962-970. PubMed ID: 35996267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemerin/CMKLR1 pathway exacerbates cisplatin-induced spiral ganglion neuron injury.
    Tian J; Mu Y; Ma L
    Toxicol Res; 2024 Jan; 40(1):73-81. PubMed ID: 38223664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.
    Graham KL; Zhang JV; Lewén S; Burke TM; Dang T; Zoudilova M; Sobel RA; Butcher EC; Zabel BA
    PLoS One; 2014; 9(12):e112925. PubMed ID: 25437209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Regulatory Roles of Chemerin-Chemokine-Like Receptor 1 Axis in Placental Development and Vascular Remodeling During Early Pregnancy.
    Zhang Q; Xiao Z; Lee CL; Duan YG; Fan X; Yeung WSB; Chiu PCN; Zhang JV
    Front Cell Dev Biol; 2022; 10():883636. PubMed ID: 35656551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
    Kumar V; LaJevic M; Pandrala M; Jacobo SA; Malhotra SV; Zabel BA
    Sci Rep; 2019 May; 9(1):7178. PubMed ID: 31073181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chemerin-CMKLR1 Axis is Functionally important for Central Regulation of Energy Homeostasis.
    Yun H; Dumbell R; Hanna K; Bowen J; McLean SL; Kantamneni S; Pors K; Wu QF; Helfer G
    Front Physiol; 2022; 13():897105. PubMed ID: 35711300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemerin promotes the pathogenesis of preeclampsia by activating CMKLR1/p-Akt/CEBPɑ axis and inducing M1 macrophage polarization.
    Ji ZS; Jiang H; Xie Y; Wei QP; Yin XF; Ye JH; Quan XZ; Lan YL; Zhao M; Tian XL; Zhang YJ; Yang XZ
    Cell Biol Toxicol; 2022 Aug; 38(4):611-628. PubMed ID: 34398343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMKLR1 deficiency attenuates androgen-induced lipid accumulation in mice.
    Huang B; Zhao H; Huang C; Wu L; Xiang L; Chen J; Wang B; Xiao T; Li M; Ren L; Niu J; Zhang JV
    Am J Physiol Endocrinol Metab; 2020 Mar; 318(3):E371-E380. PubMed ID: 31910029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner.
    Wu J; Shen S; Liu T; Ren X; Zhu C; Liang Q; Cui X; Chen L; Cheng P; Cheng W; Wu A
    Oncogene; 2022 May; 41(21):3024-3036. PubMed ID: 35459783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviative Effects of Adipose Tissue-derived Stem Cells and α-NETA on Metabolic, Biochemical, and Endocrine Parameters in a Letrozole-induced Rat Model of PCOS.
    Nejabati HR; Nikzad S; Roshangar L
    Curr Pharm Des; 2023; 29(24):1929-1938. PubMed ID: 37584355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of chemerin/CMKLR1 in the maintenance of early pregnancy.
    Yang X; Yao J; Wei Q; Ye J; Yin X; Quan X; Lan Y; Xing H
    Front Med; 2018 Oct; 12(5):525-532. PubMed ID: 29556954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CMKLR1 in endometriosis and its relationship with inflammatory responses.
    Zhang Z; Ding Y; Li J; Su S
    Histol Histopathol; 2023 Mar; 38(3):329-337. PubMed ID: 36156768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial chemerin-CMKLR1 signaling restricts microbiota-driven colonic neutrophilia and tumorigenesis by up-regulating lactoperoxidase.
    Lin Y; Cai Q; Luo Y; Li B; Chen Y; Yang X; Xuan Y; Yang H; He R
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2205574119. PubMed ID: 35858331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2.
    Kumar JD; Aolymat I; Tiszlavicz L; Reisz Z; Garalla HM; Beynon R; Simpson D; Dockray GJ; Varro A
    Oncotarget; 2019 Jan; 10(2):98-112. PubMed ID: 30719206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and β-arrestin 2 in inflammatory macrophages.
    Serafin DS; Allyn B; Sassano MF; Timoshchenko RG; Mattox D; Brozowski JM; Siderovski DP; Truong YK; Esserman D; Tarrant TK; Billard MJ
    Mol Immunol; 2019 Feb; 106():12-21. PubMed ID: 30576947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of chemerin or chemokine-like receptor 1 loss on the mouse gut microbiome.
    Dranse HJ; Zheng A; Comeau AM; Langille MGI; Zabel BA; Sinal CJ
    PeerJ; 2018; 6():e5494. PubMed ID: 30225164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.